FAQ

All the answers to the questions you have.

Do you want to join a growing international French company and a team that values each individual? Consult our Career page and our corporate page on LinkedIn. Apply for our job offers or send us your spontaneous application at service-rh@sebbin.com.

At the forefront of innovation and cutting-edge surgical technologies, we help surgeons to train through our Sebbin University training program, offering live surgeries or workshops that we hold all around the world. These interventions cover various plastic surgery specialties, from composite breast augmentation to implant-based reconstruction, facial lipofilling or gluteal augmentation surgeries.

The Sebbin University, solid training program, is also a moment of exchange and fellowship, bringing together health professionals who are partners of the Sebbin.

Please contact us at the following email address: contact@sebbin.com .
We will take note of your request and respond to it as soon as possible, directing you to the appropriate person, depending on your geographic area.

Sebbin is present worldwide.
Its headquarter is located in France, in Boissy l’Aillerie, in the Val d’Oise department near Paris. Sebbin has subsidiaries in several European countries: United Kingdom, Spain, Belgium and Switzerland (Benelux area), Germany and Austria.
Its distribution network covers several geographic areas within several continents: Europe, the Middle East, Asia-Pacific and Latin America, which gives Sebbin a presence in more than 60 countries around the world.

Autoimmune Syndrome Induced by Adjuvants (ASIA) is characterized, in its most serious forms, by the development of autoimmune diseases such as skin diseases (scleroderma, lupus), or bone and muscle pain (fibromyalgia, rheumatoid arthritis).

In a report published in 1998, an American scientific jury (US National Science Panel), evaluated the scientific data concerning silicone mammary implants with respect to their relationship with connective tissue disorders and immunological dysfunctions. No relationship was established between mammary implants prefilled with silicone gel and any of the specified connective tissue disorders or any other autoimmune/rheumatic disease. It was established that women with silicone mammary implants did not present systemic anomalies of the types or functions of immune system cells that could be attributed to silicone. In 1999, an independent report presented by a committee of the Institute of Medicine in the United States indicated that connective tissue disorders, cancer, neurological diseases and other systemic diseases are no more common in women with mammary implants than in women without. This committee concluded that an examination of toxicological studies on silicones and other substances known to be present in implants did not give any reason for concern about health.

However, certain recent studies, notably those of Colaris et al., published in July 2016 in the journal “Immunologic Research”, suggest the existence of a risk of “Autoimmune/inflammatory syndrome induced by the adjuvants” (ASIA), which could be caused by incompatibility with silicone, with the following possible main symptoms: fever, muscle and joint pain, chronic fatigue, neurological manifestations and deterioration of cognitive faculties. However, the authors state that experimental and epidemiological data are lacking to confirm the existence of this risk. For prudence, implantation is not recommended in patients having personal or family prior history of such pathologies.

Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a cancer of the immune system. In most cases, BIA-ALCL is found in the scar tissue and fluid near the implant. An individual’s risk of developing BIA-ALCL is considered to be low.

The main symptoms of BIA-ALCL are persistent swelling, presence of a mass or pain in the area of the breast implant. Sometimes, only a very abundant effusion of liquid around the implant can constitute a warning sign. The recurrent character after puncture of this fluid effusion, can evoke this disease. If you experience any of these symptoms or other changes, contact your surgeon for further evaluation (physical exam, imaging, and/or assessment of the fluid or tissue around the breast implant).

For most patients, it is treated successfully with surgery to remove the implant and surrounding scar tissue. This disease seems to be able to be induced by the inflammation created by the surface of the implants. Certain types of textures were recently banned by a couple of countries because they would represent a higher risk for developing BIA-ALCL, without the exact origin of the pathology being known. As soon as the first warning was issued by the FDA (Food and Drug Administration) in 2016 on a possible association between some breast implant surfaces and the onset of BIA-ALCL, SEBBIN decided to launch, in collaboration with two laboratories, a PhD thesis on the biocompatibility of textures, which is now completed. The results of this thesis made it possible to establish a new classification of textures aimed at avoiding any confusion around the word “textured” ((“Surface texturation of breast implant impacts extracellular matrix and inflammatory gene expression in asymptomatic capsule. Plastic and reconstructive surgery”, Brigaud I, Garabedian C, Bricout N, Pieuchot L, Ponche A, Deltombe R, et al. Dec 23, 2019.)).
Anaplastic large cell lymphoma (BIA-ALCL) remains very rare, however, it constitutes a risk of which women candidates for breast implantation must be informed.

Formatting a capsule around a breast implant is a natural reaction of your body.

Just like your body protects you by healing and creating new skin after a cut, when a foreign body is placed, the body’s immune system try to isolate it by creating a capsule of fibrous tissue.

The formation of this capsule generally occures in the first months following the operation. The capsule depends on many things, including the surgical operation and each patient’s own body reaction. This fibrous tissue can contract and may sometimes result in a hardening of the capsule, thus hardening and deformation of the breast. This is called “capsular contracture”. This can occur on one side (one breast) or on both sides (both breasts). In most cases, the capsular contracture is minor.

Capsular contractures have been classified in four grades by Dr Baker.
– Grade I corresponds to the natural capsule formed aroung a foreign body, without any negative effect (the breast is flexible).
– Grade II corresponds to the moment when the capsule is firmer and perceptible. Some patients like this development as their all breast feel firmer.
– Grade III might have an aesthetically impact, as the capsule is visible beneath the skin and the implants start to deform. A re-operation may be necessary in most cases.
– Grade IV can cause pain. The capsular contracture and deformation is stronger.

Symptoms of capsular contracture include: hardening of the breast(s), a deformed breast implant and/or appearing to be placed higher on the rib cage, ripples of the skin, breast pain.

If you experience any of these symptoms or other changes, notify your surgeon for further evaluation. He/She will be able to advise you.

If you experience any particular discomfort, unusual symptoms, or have questions about your implant, contact your surgeon. He will be able to answer your questions and direct you to the appropriate resources.

A breast implant is not a lifetime device; like any biomaterial, it ages, it wears out and its lifespan is not known with exactitude. It depends on the activities of the individual, as well as the reaction of his body towards the implant. It is generally advisable to consult your surgeon every 12 to 18 months for follow-up, and to change the implant every 10 years.

In general, there is no contraindication to breastfeeding after implantation, regardless of the type of device; however, it can be compromised in the event that, during the intervention, the milk ducts are cut. A breast abscess, if it occurs during breastfeeding, may require removal of the implant. A study, carried out by Semple et al, using silicon (very abundant in nature and from which silicone is derived) as a unit of measurement, found that the quantity found in the milk of women with implant implants is identical to the quantity found in that of women without implant.

For the serenity of patients, Sebbin offers a long-term warranty program covering its entire range of breast implants pre-filled with silicone gel. Find more information on our Warranty page. For any questions, you can also contact your surgeon.

Breast reconstruction can be performed at the same time as the mastectomy, this is called immediate reconstruction. The duration of the intervention is longer than the deferred reconstruction but allows you, when you wake up, to have your breast rebuilt even if it will not take its final shape after several months. If the reconstruction takes place in a second operative phase (after the mastectomy), we speak of deferred reconstruction. It will require a second intervention and will require you to bear for a longer or shorter time the absence of a breast.

Your surgeon will invite you for a follow up visit after your surgery. During the first year, a consultation is recommended at 3, 6 and 12 months and if during this time, you experience any concerns, your surgeon will advise the appopriate action which may include an MRI (Magnetic Resonance Imaging) or an ultrasound scan.

After the surgery, a compression bandage will prevent the prostheses from moving. As soon as you leave the block and for about 1 month, your surgeon will advise you to wear a supportive bra day and night. Some pain may be felt the following days because the breasts remain swollen and can pull up to the pectoral muscle. Avoid wide arm movements for at least 3 days, avoid driving the first 2 weeks and carrying heavy loads. Sport is to be excluded for 4 to 6 weeks minimum. No exposure to the sun for a month for good healing! And of course, no sleep on your stomach…

Expect to spend 1 to 2 hours in the recovery room. The anesthesia team will ensure that you wake up in the best conditions. In some cases, the intervention will be performed as outpatient (the patient arrives in the morning and leaves at the end of the day), otherwise it may require 1 to 2 days of hospitalization. It is followed by a rest of 5 to 10 days.

In cosmetic surgeries, the implant is inserted under the gland (retroglandular position) or under the pectoralis major muscle (retropectoral position). The incision is made either at the areola, in the hollow of the armpit or in the groove located under the breast. The scars will be hidden around the perimeter of the areola. In most cases of breast augmentation, the intervention is short. It is performed in the operating room, under general anesthesia. During reconstruction, the surgeon uses the scar left by the mastectomy to insert the implant. The intervention can sometimes take longer.

For a smooth intervention, the surgeon and anesthesiologist will need to know your medical history. Your surgeon will recommend the insertion approach (sub-mammary, peri-areolar or axillary approach) and the positioning of the implant (under the mammary gland or under the pectoral muscle) in line with your morphology and, as for any intervention, he/she will make you aware of the standard “informed consent” that you will have to approve and sign.

An implant, even perfectly tolerated, can be perceptible, visible or detectable as a whole; it may be possible to palpate its peripheral edges. The perception of a device varies according to its positioning, its content and the thickness of the mammary gland and tissues. In general, the visibility is less in case of implantation behind the muscle. In reconstructive surgeries, after a mastectomy, the implant is always palpable regardless of its location, due to the absence of mammary gland.

Breast implant surgeries must be performed by a trained and certified surgeon. A plastic surgeon is a surgeon qualified to perform plastic, reconstructive and aesthetic surgeries. You can consult international associations of surgeons such as ISAPS, EURAPS, FILACP, EASAPS to find recommendations.
When making your choice, do not hesitate to consult different surgeons as building a relationship betwen the patient and the surgeon that is based on trust is essential.

It varies according to various elements: the country you live in, the type of implant, the place of the intervention (clinic or hospital), the duration of the hospitalization, the fees of the surgeon and the anesthesiologist. After a mammectomy, the care can be taken over by the health insurance that apply in your country. In the context of a purely aesthetic intervention, the cost is totally the responsibility of the patient.

When the implant is placed between the mammary gland and the pectoral muscle, the postoperative course is not painful. You may only feel a breast tension for a few days. When the device is positioned behind the pectoralis muscle, the operative follow-ups are generally more painful and may require taking analgesics for a few days. The degree of pain is also directly related to individual factors such as, among others, the adequacy between the volume of the chosen implant and the elasticity of the skin.

Sebbin offers a wide range of silicone implants with different shapes, textures and more or less cohesive gels, to meet the wishes and needs of everyone. Your surgeon can help you choose the model that suits you, by taking precise measurements and photos of your chest. Thanks to an online simulation tool, you will be able to simulate the final rendering in augmented reality. Your surgeon may also suggest that you compare the different Sebbin models by placing sizers in your bra, in order to compare the different possible projections.

Silicone comes from silicon, which is found, among other things, in sand. Silicon becomes silicone when combined with oxygen, carbon and hydrogen. It can be found in the forms of gel, oil or gum depending on the combinations of each chemical element that composes it. Silicone is an inert material used since 1946 in the medical field. It has been used in the manufacture of intraocular lenses, pacemakers and of course in the manufacture of breast implants since 1963. Its main quality is that it does not cause a significant reaction of the body. Its mechanical qualities give it great impact resistance.

An implant is made of a flexible envelope of silicone elastomer that gives the desired shape to the prosthesis and serves as interface with the body. This envelope closed by an occlusion patch (also made of silicone), can either be sold empty to be filled by the surgeon with physiological saline during the surgery (implant called “inflatable”), or sold pre-filled with cohesive silicone gel.

Sebbin offers a large range of quality standard or custom-made medical devices:
– Implants for the body (breast, gluteal, testicular, calf, thoracic)
– Implants for the face (chin and malar) – Skin expanders
– Lipofilling and acellular matrices

You did not find an answer to one of your questions? If you want to contact us directly, you can do so by filling out our Contact Form. We will respond as soon as possible.